Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
about
sameAs
Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infantsSurfactant for meconium aspiration syndrome in term and late preterm infantsAnimal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndromeAnimal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndromeComparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infantsNebulised surfactant in preterm infants with or at risk of respiratory distress syndromeSurfactant therapy for bronchiolitis in critically ill infantsProphylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infantsSurfactant for pulmonary haemorrhage in neonatesEarly versus delayed selective surfactant treatment for neonatal respiratory distress syndromeSurfactant for bacterial pneumonia in late preterm and term infantsLaryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndromePharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndromeSurfactant therapy for bronchiolitis in critically ill infantsProtein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndromeIntra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newbornsSurfactant for bacterial pneumonia in term and late preterm infantsSurfactant therapy for bronchiolitis in critically ill infantsMultiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndromeLaryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndromePharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndromeAnimal derived surfactant extract for treatment of respiratory distress syndromeNebulised surfactant for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndromeProtein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndromeProtein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndromeSurfactant therapy for bronchiolitis in critically ill infantsLong versus short inspiratory times in neonates receiving mechanical ventilationThe use of surfactant in the neonatal period- the known aspects, those still under research and those which need to be investigated furtherNew surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambsGlobal report on preterm birth and stillbirth (3 of 7): evidence for effectiveness of interventions.Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.The role of surfactant in respiratory distress syndromeMortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study.Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?Surfactant therapy: the current practice and the future trends.Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trialsSurfactant respiratory therapy using Surfaxin/sinapultide.Prevention and management of bronchopulmonary dysplasia: Lessons learned from the neonatal research network.Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial.Evidence Based Medicine Series: Part 4. Why Some Good Studies with Clinically Important Results Cannot be Applied to Our Patients.
P2860
Q24187014-E60D73A8-35A4-46B2-9E5D-A10349F650C6Q24187318-F1768F21-14BD-4608-899A-768039CAB26DQ24187777-E1BC4EE9-1A01-4164-B146-3A911D6A451AQ24187839-A2F2BAA8-A8F3-45B5-B007-AB50482D260CQ24197942-3C550D61-1E01-4CAC-BBF9-D11C82E7D255Q24198153-FBABD26A-BFE7-439E-8A82-90515DA9427AQ24200647-F07D155E-4DD3-432A-928A-06254E14A9B5Q24201075-FB09A43E-D5D7-4C89-BF6B-BCF907BE23B7Q24201963-83873FDA-48A5-4D37-8BD3-033EAECEEAD0Q24202890-3CE5F582-5AC8-486C-A790-A72BAC633713Q24203694-E1D96A30-B86E-4091-83FA-8B2F75796577Q24235572-43DBDC53-E4DE-4869-857B-14F9BE7E42BDQ24235658-F16EBD9F-D043-4269-B627-FC3EBACEB1CFQ24236066-3944A5AA-3E79-4DE2-9FE5-FAB144D6D54FQ24240106-9516479D-A2F6-4EA7-9B99-CDE99EE53CEDQ24240793-C64D494C-BA0A-42BB-AEE6-2B2114C1B2C2Q24240870-3D174E4E-4CE0-46A9-A356-6EDEDDCE4826Q24241134-B2D645E5-2487-4C89-B047-AF8AF4ADDCFCQ24241249-3B0D00F6-9109-4E03-9F53-79F67F012DE9Q24241523-17E8D79B-DFC4-4CD0-AC7C-1448B6859905Q24241537-D6A6F684-7193-46C3-9E41-232FCC323FD2Q24241741-AB2C7512-7CA3-4BF6-A2BC-60BF8DA8F4CCQ24241781-6D289349-2F08-4E09-B226-2886EA318FBBQ24243198-58C9440F-9046-4605-97BE-912AA48376E7Q24244224-256FA724-3CDB-49D1-A643-5C05FFF5E266Q24245016-8644DC51-49D0-4C7F-A04E-812071958442Q24247753-38D924B1-F210-4546-87AB-9CC97A0C3AAAQ26864160-088C27DA-5083-496C-8098-DDF542F8B5B4Q27313764-AB65BA48-7A87-420B-998D-781705C5E2A4Q30227236-246E0C6A-A4CB-46DF-88D1-5E7CC19E1310Q35086075-F8598AC2-7B34-47F0-AB16-B07B8613AD0BQ36131235-A9F54B79-C327-4C7D-92D7-85C810B49BDDQ36572921-61224EC9-891A-4937-8DC4-3EC0A5C588B5Q36902581-D130B07E-B74F-4BED-84D2-7A0AB4132E0EQ37106212-023D6978-F0B3-435A-8AB5-EDC7AE758598Q37230260-1DF22FC6-8A04-4A11-BA67-E9CF553A4E25Q37362645-8E735C0E-25EE-4D55-B058-5E4AF80512C8Q37613608-D28BFF75-AF41-46A4-8CFC-D3FE9D69A033Q37631249-84FDB94A-3F5F-429F-9AF6-8C809662663BQ38326438-600AC39A-482A-4819-A801-C6BF48361256
P2860
Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Natural surfactant extract ver ...... respiratory distress syndrome
@nl
Natural surfactant extract ver ...... respiratory distress syndrome.
@ast
Natural surfactant extract ver ...... respiratory distress syndrome.
@en
type
label
Natural surfactant extract ver ...... respiratory distress syndrome
@nl
Natural surfactant extract ver ...... respiratory distress syndrome.
@ast
Natural surfactant extract ver ...... respiratory distress syndrome.
@en
altLabel
Natural surfactant extract ver ...... respiratory distress syndrome
@en
prefLabel
Natural surfactant extract ver ...... respiratory distress syndrome
@nl
Natural surfactant extract ver ...... respiratory distress syndrome.
@ast
Natural surfactant extract ver ...... respiratory distress syndrome.
@en
P2860
P1476
Natural surfactant extract ver ...... respiratory distress syndrome
@en
Natural surfactant extract ver ...... respiratory distress syndrome.
@en
P2093
P2860
P304
P356
10.1002/14651858.CD000144
P407
P577
2000-01-01T00:00:00Z
2001-01-01T00:00:00Z